← Back to Clinical Trials
Recruiting NCT07364240

NCT07364240 Effect of Person-Centered Occupational Therapy Interventions for Substance Use Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07364240
Status Recruiting
Phase
Sponsor Hacettepe University
Condition Substance Use Disorder (SUD)
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2026-01-27
Primary Completion 2026-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Awareness TrainingPerson-Centered Occupational Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2026-01-27 with a primary completion date of 2026-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study investigates the impact of person-centered occupational therapy interventions on individuals diagnosed with substance use disorder. Substance use often leads to isolation and difficulties in daily activities such as work, self-care, and leisure time. The research aims to evaluate how a tailored 8-week therapy program affects participants' occupational performance, self-efficacy, and psychological resilience. Participants will be divided into a study group receiving therapy and a control group.

Eligibility Criteria

Inclusion Criteria: * Being diagnosed with substance use disorder according to DSM-5 criteria. * Having completed the detoxification process. * Being between the ages of 18-65. * Having at least a primary school education. * Volunteering to participate and signing the informed consent. Exclusion Criteria: * Being in an acute psychotic episode. * Having severe neurological deficits that prevent responding to assessments. -Having severe visual or hearing loss that prevents completing the test batteries

Contact & Investigator

Central Contact

Büşra Yuvalı, PhD Cand

✉ busra.atmaca@hacettepe.edu.tr

📞 +90 532 772 43 34

Principal Investigator

Onur Altuntaş, Assoc Prof

STUDY DIRECTOR

Hacettepe University

Frequently Asked Questions

Who can join the NCT07364240 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Substance Use Disorder (SUD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07364240 currently recruiting?

Yes, NCT07364240 is actively recruiting participants. Contact the research team at busra.atmaca@hacettepe.edu.tr for enrollment information.

Where is the NCT07364240 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07364240 clinical trial?

NCT07364240 is sponsored by Hacettepe University. The principal investigator is Onur Altuntaş, Assoc Prof at Hacettepe University. The trial plans to enroll 34 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology